Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
- Published in:
- PLoS ONE, 2018, v. 13, n. 11, p. 1, doi. 10.1371/journal.pone.0207479
- By:
- Publication type:
- Article
Works by Hazou, Wadi
Results: 6
1
2
A Validated Score Assessing the Risk of an Intra-Abdominal Abscess in Patients with Crohn's Disease Presenting at the Emergency Department.
- Published in:
- Journal of Crohn's & Colitis, 2019, v. 13, n. 9, p. 1131, doi. 10.1093/ecco-jcc/jjz043
- By:
- Publication type:
- Article
3
Nonattendance to gastroenterologist follow-up after discharge is associated with a thirty-days re-admission in patients with inflammatory bowel disease: a multicenter study.
- Published in:
- Minerva Medica, 2021, v. 112, n. 4, p. 467, doi. 10.23736/S0026-4806.21.07442-5
- By:
- Publication type:
- Article
4
Editorial: targeting aberrant hepatic inflammation for treatment of non‐alcoholic steatohepatitis—authors' reply.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
5
Randomised clinical trial: A phase 2 double‐blind study of namodenoson in non‐alcoholic fatty liver disease and steatohepatitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 11, p. 1405, doi. 10.1111/apt.16664
- By:
- Publication type:
- Article
6
State of the art review with literature summary on gastric peroral endoscopic pyloromyotomy for gastroparesis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2018, v. 33, n. 11, p. 1829, doi. 10.1111/jgh.14293
- By:
- Publication type:
- Article